Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid

BioTechGrid

  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
Posted inBiotechnology

Depressive Symptoms Linked to Motoric Cognitive Risk

May 5, 2026
Continue Reading
depressive-symptoms-linked-to-motoric-cognitive-risk
Posted inBiotechnology

Predicting Coronary Artery Aneurysms in Kawasaki Disease

May 5, 2026
Continue Reading
predicting-coronary-artery-aneurysms-in-kawasaki-disease
Posted inBiotechnology

Breakthrough Study Advances Personalized Treatment for Parkinson’s Disease

May 5, 2026
Continue Reading
breakthrough-study-advances-personalized-treatment-for-parkinson’s-disease
Posted inBiotechnology

School Fitness Testing: Challenges and New Opportunities

May 5, 2026
Continue Reading
school-fitness-testing:-challenges-and-new-opportunities
Posted inBiotechnology

ZNF473 Drives Colorectal Cancer, Boosts Chemoresistance

May 5, 2026
Continue Reading
znf473-drives-colorectal-cancer,-boosts-chemoresistance
Posted inBiotechnology

All-Metal Biodegradable Microrobots Set to Revolutionize Drug Delivery and Biopsy Techniques

May 5, 2026
Continue Reading
all-metal-biodegradable-microrobots-set-to-revolutionize-drug-delivery-and-biopsy-techniques
Most Popular Post
exploring-the-future-of-healthcare with-panos-karelis
Posted inArtificial intelligence

Exploring the Future of Healthcare with Panos Karelis

exploring-the-future-of-healthcare with-gordon-wishart,-check4cancer
Posted inArtificial intelligence

Exploring the Future of Healthcare with Gordon Wishart, Check4Cancer

exploring-the-future-of-healthcare with-noam-shomron,-tel-aviv-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Noam Shomron, Tel Aviv University

exploring-the-future-of-healthcare with-raul-villamarin-rodriguez,-woxsen-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Raul Villamarin Rodriguez, Woxsen University

spatial-transcriptomic-clocks-reveal-local-cellular-interactions-influence-brain-aging
Posted inGenetics

Spatial Transcriptomic Clocks Reveal Local Cellular Interactions Influence Brain Aging

December 18, 2024
Certain cells in the brain create a nurturing environment, enhancing the health and resilience of their neighbors, while others promote…
Read More
novartis,-bioage-take-on-age-related-diseases-in-$550m-pact
Posted inBiotechnology

Novartis, BioAge take on age-related diseases in $550M pact

December 18, 2024
Freshly public BioAge Labs has secured a multi-year partnership with Novartis that focuses on age-related diseases and includes the possibility…
Read More
roche-to-bring-mass-spec-to-routine-labs-with-new-cobas-system’s-european-approval
Posted inMedical Technology

Roche to bring mass spec to routine labs with new cobas system’s European approval

December 18, 2024
Roche has begun rolling out a new diagnostics system that aims to bring the gold-standard accuracy of mass spectrometry to…
Read More
fibrosis-focused-tvardi-to-go-public-via-merger-with-cash-strapped-cara
Posted inBiotechnology

Fibrosis-focused Tvardi to go public via merger with cash-strapped Cara

December 18, 2024
Pruritus drug developer Cara Therapeutics kicked off the year halving its headcount, and the biotech has now found a new…
Read More
merck-&-co.-boosts-glp-1-portfolio-by-paying-$112m-upfront-for-hansoh’s-preclinical-drug
Posted inBiotechnology

Merck & Co. boosts GLP-1 portfolio by paying $112M upfront for Hansoh’s preclinical drug

December 18, 2024
Merck & Co. has added a second GLP-1 candidate to its pipeline, paying China’s Hansoh Pharma $112 million upfront for…
Read More
aurion’s-regenerative-eye-disease-med-improves-vision-in-phase-1/2-trial
Posted inBiotechnology

Aurion’s regenerative eye disease med improves vision in phase 1/2 trial

December 18, 2024
The highest dose of Aurion Biotech’s cell therapy, the main component of which recently received approval in Japan, has improved…
Read More
cognition’s-phase-2-shimmer-results-finally-allow-dementia-drug-to-shine
Posted inBiotechnology

Cognition’s phase 2 SHIMMER results finally allow dementia drug to shine

December 18, 2024
The failure of Cognition Therapeutics’ Alzheimer’s disease candidate CT1812 in the SHINE trial earlier this year may have rubbed off…
Read More
nvidia’s-venture-arm-raises-stake-in-ai-drug-discoverer-genesis-therapeutics
Posted inGenetics

Nvidia’s Venture Arm Raises Stake in AI Drug Discoverer Genesis Therapeutics

December 18, 2024
Evan Feinberg, PhD, founder and CEO of Genesis Therapeutics In the beginning, Genesis Therapeutics spun out from the Stanford University…
Read More
how-the-inflammatory-process-is-influenced-by-the-circadian-rhythm
Posted inGenetics

How the Inflammatory Process Is Influenced by the Circadian Rhythm

December 18, 2024
There are various studies that have explored the role of the body’s circadian rhythm in regulating immune activity. Disruptions in…
Read More
novo-nordisk-taps-photys-for-$186m-cardiometabolic-collab
Posted inBiotechnology

Novo Nordisk taps Photys for $186M cardiometabolic collab

December 17, 2024
With Novo Nordisk’s name already synonymous with treatments for diabetes and obesity, the Danish drugmaker has been making a concerted…
Read More

Posts pagination

Previous page 1 … 1,773 1,774 1,775 1,776 1,777 … 1,784 Next page
You May Have Missed
nuvalent-teams-up-with-guardant-health-for-companion-diagnostics
Posted inMedical Technology

Nuvalent teams up with Guardant Health for companion diagnostics

genomics-inks-partnership-deal-with-greywolf-to-assess-gene-datasets
Posted inMedical Technology

Genomics inks partnership deal with Greywolf to assess gene datasets

labcorp-raises-full-year-guidance,-boosted-by-diagnostics,-lab-services
Posted inMedical Technology

Labcorp raises full-year guidance, boosted by diagnostics, lab services

caredx-expands-into-cancer-testing-with-$260m-naveris-buy
Posted inMedical Technology

CareDx expands into cancer testing with $260M Naveris buy

Privacy Policy    Terms

Scroll to Top